SCHEMBL5307472

SCHEMBL5307472

CC(C)(C)OC(=O)N1CC(=O)NC(CO)C1

nearest known ligand 0.48

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 2/20 0.48
DDB1 Q16531 4/20 0.41
CRBN Q96SW2 4/20 0.41
KDM4E B2RXH2 2/20 0.39
MAPT P10636 1/20 0.39
THRB P10828 1/20 0.39
NAMPT P43490 1/20 0.38
HPGD P15428 1/20 0.38
PREP P48147 1/20 0.36
USP2 O75604 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
RECQL P46063 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20304965 1.00 NR1H2 (0.48) NR1H2DDB1CRBNKDM4EMAPT
SCHEMBL6717799 1.00 NR1H2 (0.48) NR1H2DDB1CRBNKDM4EMAPT
SCHEMBL14518857 0.86 NR1H2 (0.40) NR1H2DDB1CRBNKDM4EMAPT
SCHEMBL19382853 0.84 NR1H2 (0.44) NR1H2DDB1CRBNKDM4EMAPT
SCHEMBL1344422 0.84 NR1H2 (0.44) NR1H2DDB1CRBNKDM4EMAPT
SCHEMBL7498390 0.82 DDB1 (0.37) NR1H2DDB1CRBNKDM4EMAPT
SCHEMBL29187033 0.81 DDB1 (0.36) NR1H2DDB1CRBNKDM4EMAPT
SCHEMBL29231907 0.81 DDB1 (0.36) NR1H2DDB1CRBNKDM4EMAPT
SCHEMBL28713661 0.81 DDB1 (0.36) NR1H2DDB1CRBNKDM4EMAPT
SCHEMBL15971534 0.81 PRKCD (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117813302-A Substituted tetrahydrofuran-2-carboxamides as sodium channel modulators 沃泰克斯药物股份有限公司 2024-04-02 CN disclosed
WO-2007034445-A2 NOVEL PIPERAZINE DERIVATIVES AS RENIN INHIBITORS FOR CARDIOVASCULAR EVENTS AND RENAL INSUFFICIENCY ACTELION PHARMACEUTICALS LTD (CH) 2007-03-29 WO disclosed
WO-2007034445-A2 NOVEL PIPERAZINE DERIVATIVES AS RENIN INHIBITORS FOR CARDIOVASCULAR EVENTS AND RENAL INSUFFICIENCY ACTELION PHARMACEUTICALS LTD (CH) 2007-03-29 WO disclosed